A GLANCE ON PHARMACOGENOMICS BASIS ON GENETIC DISORDERS AND ADVANCES IN RECOMBINANT-DNA TECHNOLOGY AS A NEW APPROACH

Journal Title: Mintage journal of pharmaceutical and medical sciences - Year 2018, Vol 7, Issue 7

Abstract

Background: Advent of r-DNA techniques and their application to biology and healthcare system is one of the most exciting eras of scientific history. Objectives: In this review, we discuss about pharmacogenetics, pharmacogenomics, advances, applications, challenges and future perspectives of r-DNA technology. Variability in drug responses is the net result of multiple interacting genes and environmental factors. Conclusion: We found that many technical and conceptual barriers still remain unveil to the world, if the true potential of this field recognize, the genetic disorders will completely disappear and will get a solution for most questionable microbial resistance. It is anticipated that less than 10% of drugs in 10 years from now will be prescribed following a pharmacogenetic test. In future, we need more intensive studies in the areas of pharmacogenomics to identify the targeted gene which is responsible for specific diseases or variable drug response, so the r-DNA technology can easily develop a new drug molecule which can change the gene expression or may modify the targeted gene. Field of pharmacogenomics will lead to new important insights and discoveries that will ultimately lead to the development of new and better drugs and to the rational use of drugs that are already on the market.

Authors and Affiliations

Dr. Krishna Ravi, Sudha M, Dr. Venkateswarmurthy, Dr. Sambathkumar R

Keywords

Related Articles

TO DESIGN MICROSPHERES OF THE ANTIBACTERIAL DRUG CEFACLOR AND OPTIMIZE ITS CHARACTERISTICS

Aim: This study aims to design microspheres of the antibacterial drug Cefaclor and optimize its characteristics to improve the bioavailability as well as to reduce its side effects. This utilizes statistical software for...

A PRELIMINARY STUDY ON THE ANTIPROLIFERATIVE AND CYTOSTATIC EFFECT OF NIGERIAN HONEY

Background: Cancer is a significant health problem and also a major cause of death in both developing and developed countries all over the world. The World Health Organization (WHO) has ranked it among the leading causes...

FORMULATION AND CHARACTERIZATION OF FLOATING MICROSPHERES OF ACARBOSE BY SOLVENT EVAPORATION METHOD

Objective: The purpose of the present investigation was the formulation and characterization of Gastro-retentive floating microspheres of anti-diabetic drug Acarbose that would retain in the stomach and continuously rele...

PROCESS OPTIMIZATION AND INVITRO EVALUATION OF RISEDRONATE SODIUM IMMEDIATE RELEASE TABLETS

Objective: Present project aims to process optimize and evaluate 150mg of Risedronate Sodium tablets. Objective of the process optimization plan is to monitor the manufacturing process of Risedronate sodium tablets 150mg...

STUDY OF FEW TETRALONE DERIVATIVES

Tetralone ring system has drawn an immense attention in the field of drug discovery by virtue of their wide applications as an analgesic, antidepressant, antifungal and antibacterial. The wide range of its therapeutic ap...

Download PDF file
  • EP ID EP537102
  • DOI -
  • Views 153
  • Downloads 0

How To Cite

Dr. Krishna Ravi, Sudha M, Dr. Venkateswarmurthy, Dr. Sambathkumar R (2018). A GLANCE ON PHARMACOGENOMICS BASIS ON GENETIC DISORDERS AND ADVANCES IN RECOMBINANT-DNA TECHNOLOGY AS A NEW APPROACH. Mintage journal of pharmaceutical and medical sciences, 7(7), 1-6. https://europub.co.uk/articles/-A-537102